Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03820778 · ClinicalTrials.gov registry record · NA
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
A NA study of Neurofibromatosis 1 and Plexiform Neurofibroma, sponsored by Children's National Research Institute.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03820778 is a NA study of Neurofibromatosis 1 and Plexiform Neurofibroma that is active but no longer recruiting, run by Children's National Research Institute. The registered enrollment target is 10 participants, below the 1,035-participant average among 24 other Neurofibromatosis 1 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03820778, a NA study of Neurofibromatosis 1 and Plexiform Neurofibroma, is active but no longer recruiting, sponsored by Children's National Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to determine if Whole Body MRI (WBMRI) can be used to identify Atypical Neurofibromas (ANF) in Neurofibromatosis Type 1 (NF1) patients with high tumor burden. Each enrolled participant will have two (2) WBMRIs without sedation during the study period. Eligible participants must be Male or Female between the ages of 8-30 with diagnosed NF1; with one or more PN greater than 3cm in diameter and willing to comply with study procedures.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Whole Body MRI
Study Locations (1)
District of Columbia
- Children's National Health System - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03820778
The ClinicalTrials.gov registry entry for NCT03820778 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,035-participant average among 24 other Neurofibromatosis 1 trials with a reported enrollment target (99% lower). The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Neurofibromatosis 1 appearing as the primary indexed condition, and to 1 intervention - of which Whole Body MRI is the first listed.
NCT03820778 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03820778 about?
NCT03820778 is a clinical study titled "Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1". This study is being conducted to determine if Whole Body MRI (WBMRI) can be used to identify Atypical Neurofibromas (ANF) in Neurofibromatosis Type 1 (NF1) patients with high tumor burden. Each enrolled participant will have two (2) WBMRIs without sedation during the study period. Eligible participa...
What is the current status of trial NCT03820778?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2018-07-12. Estimated completion is 2022-08-01.
What conditions does trial NCT03820778 study?
This clinical trial studies the following conditions: Neurofibromatosis 1, Plexiform Neurofibroma, Neurofibroma, Atypical Neurofibroma, Von Recklinghausen Disease.
What interventions are being tested in trial NCT03820778?
The interventions under investigation include: Whole Body MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03820778?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03820778 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurofibromatosis 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
RECRUITING · NA
-
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
RECRUITING · NA
-
Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
RECRUITING · NA
-
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
RECRUITING
-
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RECRUITING · Phase 1
-
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
RECRUITING · Phase 2
Explore more on PlainTrial
Neurofibromatosis 1
All registered trials for this condition
Plexiform Neurofibroma
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.